en

PRODUCT DETAIL

Co-Amlessa Neo 10 mg/2,5 mg/10 mg tablety

Code 6525E
MA number 58/0150/24-S
Product Form: tbl 30x10 mg/2,5 mg/10 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09B ACE INHIBITORS, COMBINATIONS
C09BX ACE inhibitors, other combinations
C09BX01 Perindopril,amlodipine and indapamide
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 14.06.2024
Validity: 14.06.2029
PIL: PIL_Co-Amlessa Neo_06_2024.pdf  
SPC: SPC_Co-Amlessa Neo_06_2024.pdf  
Safety feature Yes
Data update: 17.06.2024
eu-flag.png sk-flag.png